| Literature DB >> 28245260 |
O Sarid1, V Slonim-Nevo1, A Pereg1, M Friger2, R Sergienko2, D Schwartz3, D Greenberg4, I Shahar1, E Chernin2, H Vardi2, L Eidelman3, A Segal3, G Ben-Yakov3, N Gaspar3, D Munteanu3, A Rozental3, A Mushkalo3, V Dizengof3, N Abu-Freha3, A Fich3, S Odes5.
Abstract
OBJECTIVE: To identify coping strategies and socio-demographics impacting satisfaction with life and quality of life in Crohn's disease (CD).Entities:
Mesh:
Year: 2017 PMID: 28245260 PMCID: PMC5330481 DOI: 10.1371/journal.pone.0172779
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Cohort characteristics (N = 402).
| Variable | Men | Women | p-value |
|---|---|---|---|
| Median (Min; Max) (IQR | Median (Min; Max) (IQR | ||
| Number in cohort | 158 (39.3%) | 244 (60.7%) | |
| Age | 36.5 ± 12.6 | 40.1 ± 14.7 | .020 |
| Education (study years) | 14 (4;23) (12;16) | 12 (5; 30) (12; 17) | .077 |
| Number of children | 1 (0; 9) (0; 3) | 2 (0; 8) (0; 3) | .127 |
| Economic status | 3 (1; 5) (3; 4) | 3 (1; 5) (3; 3) | .081 |
| Past Smoker | 78 (49.4%) | 107 (43.9%) | .229 |
| Current Smoker | 38 (24.1%) | 40 (16.4%) | .078 |
| Working | 116 (73.4%) | 153 (62.7%) | .026 |
| Family status | |||
| Married or living together | 91 (57.6%) | 151 (61.9%) | .478 |
| Single or divorced | 65 (41.1%) | 93 (38.1%) | |
| Religion | |||
| Jewish | 149 (94.3%) | 238 (97.5%) | |
| Muslim | 7 (4.4%) | 2 (0.8%) | |
| Christian | 1 (0.6%) | 1 (0.4%) | |
| Other | 0 (0%) | 3 (1.2%) | |
| Degree of religiosity | |||
| Ultra-Orthodox | 10(6.3%) | 8 (3.3%) | .104 |
| Religious | 25 (15.8%) | 27 (11.1%) | |
| Traditional | 27 (17.1%) | 60 (24.6%) | |
| Secular | 96 (60.8%) | 148 (60.7%) | |
| Place of birth | |||
| Israel | 87 (55.1%) | 129 (52.9%) | .237 |
| Asia-Africa | 7 (4.4%) | 15 (6.1%) | |
| Eastern Europe-FSU | 16 (10.1%) | 15 (6.1%) | |
| America-Western Europe | 5 (3.2%) | 15 (6.1%) | |
| Harvey-Bradshaw Index (P-HBI) | 4.75 ± 4.71 | 5.74 ± 4.71 | .010 |
| Inactive disease (P-HBI ≤4) | 94 (59.5%) | 123 (50.4%) | .074 |
| Active disease (P-HBI ≥5) | 64 (40.5%) | 121 (49.6%) | |
| Disease duration (years) | 10.8 ± 8.7 | 11.4 ± 8.56 | .318 |
| Medications | |||
| Mesalamine | 51 (32.3%) | 65 (26.6%) | .223 |
| Immunomodulators | 77 (48.7%) | 122 (50.0%) | .804 |
| Steroids | 27 (17.1%) | 55 (22.5%) | .185 |
| Biological | 72 (45.6%) | 108 (44.3%) | .797 |
| Surgery | 68 (43.0%) | 72 (29.5%) | .005 |
| Hospitalization (last year) | 35 (22.2%) | 60 (24.6%) | .547 |
* Interquartile range
** The Pearson Chi-Square test is not applicable in this case.
Descriptive values of psychological measures by disease activity and gender.
| Disease Activity | Measures (range) | Men (N = 158) | Women (N = 244) | p-value |
|---|---|---|---|---|
| Mean ± SD | Mean ± SD | |||
| Inactive | SWLS (5–35) | 23.8±6.4 | 23.8±6.7 | .977 |
| SIBDQ (10–70) | 57.4±9.8 | 52.6±10.7 | .001 | |
| Emotion-focused Coping (10–40) | 23.2±5.4 | 24.9±5.9 | .025 | |
| Problem-focused Coping (6–24) | 14.8±4.9 | 16.8±4.8 | .002 | |
| Dysfunctional Coping (12–48) | 19.8±5.9 | 21.9±5.5 | .007 | |
| Active | SWLS (5–35) | 20.0±8.6 | 20.9±7.8 | .487 |
| SIBDQ (10–70) | 39.9±12.7 | 38.1±12.2 | .345 | |
| Emotion-focused Coping (10–40) | 24.4±5.9 | 24.3±5.3 | .892 | |
| Problem-focused Coping (6–24) | 15.4±4.0 | 16.2±4.4 | .192 | |
| Dysfunctional Coping (12–48) | 23.2±5.3 | 23.4±4.9 | .573 |
*by P-HBI
SWLS, Satisfaction with life scale; SIBDQ, Short inflammatory bowel disease questionnaire
Pearson correlation coefficients matrix of the demographic, medical and psychological characteristics of the cohort.
| Economic status | No. children | P-HBI | Emotion-focused Coping Strategies | Problem-focused Coping Strategies | Dysfunctional Coping Strategies | SIBDQ | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F | M | F | M | F | M | F | M | F | M | F | M | F | M | |
| .071 | .121 | |||||||||||||
| -.162 | -.340 | .169 | .105 | |||||||||||
| .103 | -.173 | -.054 | -.067 | -.041 | .080 | |||||||||
| .029 | -.180 | -.199 | -.182 | -.058 | .021 | .605 | .563 | |||||||
| -.238 | -.278 | -.065 | .010 | .172 | .230 | .264 | .510 | .278 | .538 | |||||
| .306 | .444 | -.01 | -.081 | -.626 | -.696 | .049 | -.181 | -.048 | -.151 | -.337 | -.471 | |||
| .392 | .548 | .215 | .113 | -.241 | -.281 | .246 | -.093 | .011 | -.246 | -.214 | -.364 | .435 | .510 | |
*p≤0.05;
** p≤0.01
Correlations in bold squares indicate significant difference between the genders
Correlations between SWLS or SIBDQ with age, education and disease duration did not reach significance and therefore were not included.
Fig 1General model with path analysis showing the direct and indirect effects of economic status and number of children on SIBDQ and SWLS, with emotion-focused and dysfunctional coping strategies as mediators.
Each of the coefficients in the model exceeds p≤0.05 significance.
Comparison of structural alternative model and path magnitudes between four groups.
| Fit measures | Model comparisons | |||||||
|---|---|---|---|---|---|---|---|---|
| X2 (df) | p. model | X2/df | SRMR | RMSEA | CFI | X2 (df) difference | p. difference | |
| General model, no constraints | 6.68 (6) | 0.351 | 1.114 | 0.045 | 0.023 | 0.965 | ||
| Alternative model, without dysfunctional coping as mediator | 26.23 (7) | <0.01 | 3.74 | 0.103 | 0.113 | 0.862 | 19.55 (1) | <0.01 |
| Four groups model, no constraints | 30.36 (24) | 0.173 | 1.265 | 0.076 | 0.026 | 0.923 | ||
| Constraining five paths as follows:
Dysfunctional Coping Strategies on SIBDQ Dysfunctional Coping Strategies on SWLS Economic status on Dysfunctional Coping Strategies Number of children on SWLS Economic status on SWLS | 44.23 (39) | 0.26 | 1.134 | 0.081 | 0.018 | 0.984 | 13.86 (15) | N.S |
| Constraining two paths as follows:
Emotional cope on SWLS ES on SIBDQ | 51.55 (30) | <0.05 | 1.72 | 0.075 | 0.042 | 0.869 | 21.19(6) | <0.01 |
*Model comparisons are conducted relative to the general model and four groups, respectively
**Cohort divided by gender and disease activity state
Fig 2Four groups model path analysis, with the cohort split by gender (women, men) and disease activity (inactive disease, active disease).
All β coefficients ≥ 0.15 reached p≤0.05 significance.